110 related articles for article (PubMed ID: 22459228)
1. Saliva and blood concentration of cefuroxime in patients undergoing maxillofacial surgery.
Venetis G; Chatzika K; Pitsiou G; Kechagias N; Antoniades K; Kioumis IP
J Oral Maxillofac Surg; 2012 Jun; 70(6):1398-403. PubMed ID: 22459228
[TBL] [Abstract][Full Text] [Related]
2. Soft tissue penetration of cefuroxime determined by clinical microdialysis in morbidly obese patients undergoing abdominal surgery.
Barbour A; Schmidt S; Rout WR; Ben-David K; Burkhardt O; Derendorf H
Int J Antimicrob Agents; 2009 Sep; 34(3):231-5. PubMed ID: 19411164
[TBL] [Abstract][Full Text] [Related]
3. Influence of cardiopulmonary bypass on cefuroxime plasma concentration and pharmacokinetics in patients undergoing coronary surgery.
Ferreira F; Santos S; Nascimento J; Strabelli T; Carmona M
Eur J Cardiothorac Surg; 2012 Aug; 42(2):300-5. PubMed ID: 22290920
[TBL] [Abstract][Full Text] [Related]
4. [Excretion of beta-lactam antibiotics in human parotid saliva].
Maier H; Zerfowski M; Schlegel P
HNO; 1991 Mar; 39(3):102-7. PubMed ID: 2050551
[TBL] [Abstract][Full Text] [Related]
5. Systemic availability of prophylactic cefuroxime in patients submitted to coronary artery bypass grafting with cardiopulmonary bypass.
Nascimento JW; Carmona MJ; Strabelli TM; Auler JO; Santos SR
J Hosp Infect; 2005 Apr; 59(4):299-303. PubMed ID: 15749317
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of cefuroxime in traumatic wound secretion and antibacterial activity under vacuum therapy.
Bischoff M; Beck A; Frei P; Bischoff G
J Chemother; 2010 Apr; 22(2):92-7. PubMed ID: 20435567
[TBL] [Abstract][Full Text] [Related]
7. Cefuroxime pharmacokinetics in pediatric cardiovascular surgery patients undergoing cardiopulmonary bypass.
Knoderer CA; Saft SA; Walker SG; Rodefeld MD; Turrentine MW; Brown JW; Healy DP; Sowinski KM
J Cardiothorac Vasc Anesth; 2011 Jun; 25(3):425-30. PubMed ID: 20864357
[TBL] [Abstract][Full Text] [Related]
8. Cefuroxime plasma and tissue concentrations in patients undergoing elective cardiac surgery: Continuous vs bolus application. A pilot study.
Skhirtladze-Dworschak K; Hutschala D; Reining G; Dittrich P; Bartunek A; Dworschak M; Tschernko EM
Br J Clin Pharmacol; 2019 Apr; 85(4):818-826. PubMed ID: 30636060
[TBL] [Abstract][Full Text] [Related]
9. Bone, subcutaneous tissue and plasma pharmacokinetics of cefuroxime in total knee replacement patients - a randomized controlled trial comparing continuous and short-term infusion.
Tøttrup M; Søballe K; Bibby BM; Hardlei TF; Hansen P; Fuursted K; Birke-Sørensen H; Bue M
APMIS; 2019 Dec; 127(12):779-788. PubMed ID: 31515843
[TBL] [Abstract][Full Text] [Related]
10. Perioperative antibiotic prophylaxis with cefuroxime in oral-maxillofacial surgical procedures.
Alfter G; Schwenzer N; Friess D; Möhrle E
J Craniomaxillofac Surg; 1995 Feb; 23(1):38-41. PubMed ID: 7699082
[TBL] [Abstract][Full Text] [Related]
11. Cefazolin bolus and continuous administration for elective cardiac surgery: improved pharmacokinetic and pharmacodynamic parameters.
Adembri C; Ristori R; Chelazzi C; Arrigucci S; Cassetta MI; De Gaudio AR; Novelli A
J Thorac Cardiovasc Surg; 2010 Aug; 140(2):471-5. PubMed ID: 20570290
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of cefuroxime in infants and neonates undergoing cardiac surgery.
Gertler R; Gruber M; Wiesner G; Grassin-Delyle S; Urien S; Tassani-Prell P; Martin K
Br J Clin Pharmacol; 2018 Sep; 84(9):2020-2028. PubMed ID: 29761538
[TBL] [Abstract][Full Text] [Related]
13. Population pharmacokinetic models for cefuroxime and metronidazole used in combination as prophylactic agents in colorectal surgery: Model-based evaluation of standard dosing regimens.
Asín-Prieto E; Soraluce A; Trocóniz IF; Campo Cimarras E; Sáenz de Ugarte Sobrón J; Rodríguez-Gascón A; Isla A
Int J Antimicrob Agents; 2015 May; 45(5):504-11. PubMed ID: 25758019
[TBL] [Abstract][Full Text] [Related]
14. Ceftriaxone bone penetration in patients with septic non-union of the tibia.
Garazzino S; Aprato A; Baietto L; D'Avolio A; Maiello A; De Rosa FG; Aloj D; Siccardi M; Biasibetti A; Massè A; Di Perri G
Int J Infect Dis; 2011 Jun; 15(6):e415-21. PubMed ID: 21497532
[TBL] [Abstract][Full Text] [Related]
15. Serum concentrations of cefuroxime after continuous infusion in coronary bypass graft patients.
Pass SE; Miyagawa CI; Healy DP; Ivey TD
Ann Pharmacother; 2001 Apr; 35(4):409-13. PubMed ID: 11302401
[TBL] [Abstract][Full Text] [Related]
16. Penetration of cefuroxime in subcutaneous tissue during coronary artery bypass grafting surgery.
Nascimento JW; Carmona MJ; Strabelli TM; Auler JO; Santos SR
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Dec; 877(31):3960-4. PubMed ID: 19853540
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of cefuroxime in the groin wound after vascular prosthetic implantation.
Sørensen TS; Aabech J; Utzon NP; Bruun B; Lorentzen JE
J Vasc Surg; 1988 Aug; 8(2):143-6. PubMed ID: 3398171
[TBL] [Abstract][Full Text] [Related]
18. Achievement of therapeutic concentrations of cefuroxime in early preterm gestations with premature rupture of the membranes.
De Leeuw JW; Roumen FJ; Bouckaert PX; Cremers HM; Vree TB
Obstet Gynecol; 1993 Feb; 81(2):255-60. PubMed ID: 8423961
[TBL] [Abstract][Full Text] [Related]
19. [Single dose prevention with cefuroxime in plastic surgery. Control of serum level, efficacy and tolerance].
Abel R; Stark GB; Spilker G
Handchir Mikrochir Plast Chir; 1994 May; 26(3):156-9. PubMed ID: 8050746
[TBL] [Abstract][Full Text] [Related]
20. [Correlation of ornidazole concentration in saliva and serum of healthy volunteers].
Jiang Y; Liu HC; Wu X; Feng CZ; Chang P; Zhang XH
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Sep; 30(9):2108-10. PubMed ID: 20855263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
